Fundraising FoxDNA SEQ 2
Vista, US · Founded 2022 · Delaware corporation
Find your way into DNA SEQ 2
Sign up to see every warm intro you have to DNA SEQ 2
- Paths you didn't know you had: your email and LinkedIn already hold routes to the DNA SEQ 2 team. We find them for you
- 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
- Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone
Days of research, done the moment you sign in, with every route ranked by how warm it is.
Founders & leadership
AN
Andrew NappinExecutive
JM
Janusz Maria SowadskiNamed on SEC filing
Board
TM
Thomas M. WheelerBoard director
BA
Benjamin AndersonBoard director
SE
Stuart E. SiegelBoard director
EL
Eric LadizinskyBoard director
Reported raises · per SEC filings
Form D private placements$1.2M disclosed across 1 round · 2024
▶$1.2MraisedMar 2026 · 32 investors · PharmaceuticalsRule 506(b)
▶$1.2MraisedMar 2026 · 32 investors · Pharmaceuticals
Rule 506(b)Officers, directors & promoters on the filing
- Thomas M. WheelerDirector
- Benjamin AndersonDirector
- Stuart E. SiegelDirector
- Janusz Maria SowadskiDirector
- Eric LadizinskyDirector
- Andrew NappinExecutive Officer
- Offering amount
- $1.2M
- Amount sold
- $1.2M
- First sale
- Apr 2024
- Incorporated
- Corporation, Delaware, 2022
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.
Frequently asked questions
- How much funding has DNA SEQ 2 raised?
- DNA SEQ 2 has disclosed $1.2M raised across 1 round.
- Where is DNA SEQ 2 headquartered?
- DNA SEQ 2 is headquartered in Vista, US.